Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Eur J Gastroenterol Hepatol ; 29(7): 838-843, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28430699

ABSTRACT

BACKGROUND AND AIM: Vulval Crohn's disease (VCD) is a rare extraintestinal cutaneous manifestation of Crohn's disease. No consensus on the diagnostic workup and therapeutic management of this condition has been provided in the current literature. PATIENTS AND METHODS: Retrospective, multicentre descriptive case series of female patients diagnosed and treated with VCD. By chart review, data on initial symptoms, clinical courses, histologic findings and therapeutic management were collected. RESULTS: Fifteen female patients with a median age of 28 years (interquartile range: 28-44 years) suffering from Crohn's disease of the ileum (27%), colon (33%) and ileocolon (40%) were included. VCD manifested most frequently with vulval swelling (93%), pain (80%) and erythema (73%). Histologic analysis demonstrated granulomatous inflammation in 78% and a mixed inflammatory cell infiltrate in 67% of cases. In eight (53%) cases, topical therapy resulted in temporary reduction of vulval symptoms. Combotreatment with immunosuppressive agents and tumour necrosis factor α inhibitors was the most effective second-line therapy: five (33%) patients achieved sustained clinical remission with this therapeutic strategy. CONCLUSION: The diagnostic workup of VCD is challenging and should be approached in a multidisciplinary manner. Histopathologic analysis of the vulva supports the diagnosis. Topical therapy and systemic treatment with immunosuppressive agents and tumour necrosis factor α inhibitors are advised to treat this condition.


Subject(s)
Algorithms , Biological Products/administration & dosage , Critical Pathways , Crohn Disease/diagnosis , Crohn Disease/drug therapy , Immunosuppressive Agents/administration & dosage , Vulvar Diseases/diagnosis , Vulvar Diseases/drug therapy , Administration, Topical , Adult , Biological Products/adverse effects , Databases, Factual , Drug Therapy, Combination , Female , Humans , Immunosuppressive Agents/adverse effects , Netherlands , Patient Care Team , Predictive Value of Tests , Remission Induction , Retrospective Studies , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors
2.
Ned Tijdschr Geneeskd ; 153: B358, 2009.
Article in Dutch | MEDLINE | ID: mdl-19785805

ABSTRACT

A 58-year-old man presented with a necrotizing ulcus on his back due to a complicated fluoroscopy-guided intervention procedure a few months before with a high total radiation dose.


Subject(s)
Fluoroscopy/adverse effects , Radiation Dosage , Ulcer/etiology , Humans , Male , Middle Aged , Ulcer/pathology
3.
Int J Cancer ; 113(1): 36-41, 2005 Jan 01.
Article in English | MEDLINE | ID: mdl-15386360

ABSTRACT

Human papillomavirus (HPV) infections and HPV-associated penile lesions are frequently found in male sexual partners of women with cervical intraepithelial neoplasia (CIN). To determine the significance of these findings, we studied the prevalence of HPV and HPV associated penile lesions in a male hospital population with non-STD complaints. Penoscopy was performed after application of acetic acid to identify flat lesions, papular lesions, condylomata acuminata and pearly penile papules (PPPs). Presence of HPV DNA in penile scrapes was tested by GP5+6+ PCR. In case of HPV 16 positivity, viral loads were quantified using a LightCycler based real-time PCR method. Comparing the non-STD male hospital population (n = 118) with the male sexual partners of women with CIN (n = 238), flat penile lesions were found in 14% vs. 60% and penile HPV in 25% vs. 59% of the men, respectively. We found that the presence of penile HPV and, in case of HPV 16 positivity, higher viral loads were associated with the presence of flat penile lesions. Amongst the HPV-positive men, flat penile lesions were more common and larger in size in male sexual partners of women with CIN than in the non-STD hospital population. HPV infections and HPV-associated flat penile lesions are commonly found in the non-STD male population. However, these lesions are less frequently present and smaller in size than in male sexual partners of women with CIN. Higher viral loads in penile scrapes of male sexual partners of women with CIN are reflected by a higher prevalence of flat penile lesions and a larger size of these lesions.


Subject(s)
Inpatients/statistics & numerical data , Papillomaviridae , Papillomavirus Infections/epidemiology , Penile Diseases/epidemiology , Sexual Partners , Uterine Cervical Dysplasia , Uterine Cervical Neoplasms , Adult , Colposcopy , Female , Genotype , Humans , Male , Middle Aged , Netherlands/epidemiology , Papillomavirus Infections/complications , Papillomavirus Infections/diagnosis , Papillomavirus Infections/pathology , Penile Diseases/diagnosis , Penile Diseases/pathology , Penile Diseases/virology , Polymerase Chain Reaction , Prevalence , Uterine Cervical Neoplasms/diagnosis , Viral Load , Uterine Cervical Dysplasia/diagnosis
4.
J Pathol ; 204(1): 39-46, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15307136

ABSTRACT

Allergic contact dermatitis (ACD) is a T-cell-mediated disease in which expression of a distinct repertoire of chemokines results in the recruitment of effector T cells into the skin. While it is becoming clear which chemokines and receptors determine the development of ACD, the mechanisms involved in the retention of T cells in the skin after resolution of inflammation are still unknown. Unravelling these mechanisms will help us to understand local skin memory as observed in retest reactivity and flare-up reactions. This study was designed to evaluate the role of chemokine-chemokine receptor interactions in local T-cell retention. The results show that expression of the CCR10 targeting ligand CCL27 is not only increased during inflammation, but also remains increased several weeks after clinical responsiveness to patch testing. In parallel with increased CCL27 expression, an increased number of infiltrating cells could still be detected in skin that, clinically, had returned to normal 21 days after patch testing. These persisting cells were characterized as CD4+ cells expressing CCR10, while no CD8+ CCR10+ cells could be detected. The presence of these cells is most likely an allergen-mediated effect, as increased levels of CCL27 and CCR10 could not be detected 21 days after initiating an irritant contact dermatitis reaction. In contrast to CCL27, increased expression of CXCL9, CXCL10, and CXCL11 could only be observed during the clinically inflammatory phase of ACD. In conclusion, local CCL27-mediated retention of CCR10+ CD4+ T cells in sites previously challenged by ACD could be responsible for phenomena such as local skin memory observed in retest reactions and flare-up reactions in which the presence of persisting T cells results in an accelerated inflammatory response upon renewed allergen challenge.


Subject(s)
Chemokines, CC/metabolism , Dermatitis, Allergic Contact/immunology , Immunologic Memory , Receptors, Chemokine/metabolism , Skin/immunology , CD4-Positive T-Lymphocytes/immunology , Chemokine CCL27 , Chemokines, CC/genetics , Dermatitis, Allergic Contact/pathology , Dermatitis, Irritant/immunology , Fluorescent Antibody Technique , Gene Expression , Humans , In Situ Hybridization , Patch Tests , RNA, Messenger/genetics , Receptors, CCR10 , Receptors, Chemokine/genetics , Time Factors
6.
Curr Treat Options Gastroenterol ; 4(3): 227-243, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11469980

ABSTRACT

Extraintestinal complications of inflammatory bowel disease (IBD) are often secondary to the underlying disease. Therefore, the first priority is to get active IBD into remission with medications, since surgery for IBD is not indicated for the treatment of extraintestinal complications. Symptoms of extraintestinal complications usually can be treated with simple agents; the treatment of patients with refractory symptoms and the use of more complex drug regimens should be done in cooperation with specialists on affected organ systems. Careful consideration of prescribed drugs is necessary because they may negatively influence the course of IBD.

SELECTION OF CITATIONS
SEARCH DETAIL
...